Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines

Vaccine

Volumn 26, Issue 2, 2008, Pages 193-200

  Miura, Kazutoyo ^a   Orcutt, Andrew C ^a   Muratova, Olga V ^a   Miller, Louis H ^a   Saul, Allan ^a   Long, Carole A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Antibody; Enzyme linked immunosorbent assay (ELISA); Vaccine development

Indexed keywords

MALARIA VACCINE;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPRODUCIBILITY; RHESUS MONKEY; STANDARDIZATION;

ANIMALS; ANTIBODIES, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; MACACA MULATTA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; REPRODUCIBILITY OF RESULTS;

EID: 37249043123     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.10.064     Document Type: Article

References (18)

1. Engvall E., and Perlman P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 8 9 (1971) 871-874
2. Van Weemen B.K., and Schuurs A.H. Immunoassay using antigen-enzyme conjugates. FEBS Lett 15 3 (1971) 232-236
3. Gheesling L.L., Carlone G.M., Pais L.B., Holder P.F., Maslanka S.E., Plikaytis B.D., et al. Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J Clin Microbiol 32 6 (1994) 1475-1482
4. Player V.A., and White D. Comparison of an ELISA system for the quantification of hepatitis B antibody with an automated and a semi-automated system. J Virol Methods 45 1 (1993) 67-72
5. Voller A., Bartlett A., and Bidwell D.E. Enzyme immunoassays with special reference to ELISA techniques. J Clin Pathol 31 6 (1978) 507-520
6. Macy E., Kemeny M., and Saxon A. Enhanced ELISA: how to measure less than 10 picograms of a specific protein (immunoglobulin) in less than 8 hours. Faseb J 2 14 (1988) 3003-3009
7. Jitsukawa T., Nakajima S., Sugawara I., and Watanabe H. Increased coating efficiency of antigens and preservation of original antigenic structure after coating in ELISA. J Immunol Methods 116 2 (1989) 251-257
8. McLaren M.L., Lillywhite J.E., and Au A.C. Indirect enzyme linked immunosorbent assay (ELISA): practical aspects of standardization and quality control. Med Lab Sci 38 3 (1981) 245-251
9. Ravindranath M.H., Ravindranath R.M., Morton D.L., and Graves M.C. Factors affecting the fine specificity and sensitivity of serum antiganglioside antibodies in ELISA. J Immunol Methods 169 2 (1994) 257-272
10. Engvall E., and Perlmann P. Enzyme-linked immunosorbent assay. ELISA. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol 109 1 (1972) 129-135
11. Plested J.S., Coull P.A., and Gidney M.A. ELISA. Methods Mol Med 71 (2003) 243-261
12. Engvall E. Quantitative enzyme immunoassay (ELISA) in microbiology. Med Biol 55 4 (1977) 193-200
13. Miles A.P., Zhang Y., Saul A., and Stowers A.W. Large-scale purification and characterization of malaria vaccine candidate antigen Pvs25H for use in clinical trials. Protein Expr Purif 25 1 (2002) 87-96
14. Zou L., Miles A.P., Wang J., and Stowers A.W. Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials. Vaccine 21 15 (2003) 1650-1657
15. Kennedy M.C., Wang J., Zhang Y., Miles A.P., Chitsaz F., Saul A., et al. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Infect Immun 70 12 (2002) 6948-6960
16. Malkin E.M., Durbin A.P., Diemert D.J., Sattabongkot J., Wu Y., Miura K., et al. Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria. Vaccine 23 24 (2005) 3131-3138
17. Malkin E.M., Diemert D.J., McArthur J.H., Perreault J.R., Miles A.P., Giersing B.K., et al. Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria. Infect Immun 73 6 (2005) 3677-3685
18. Malkin E., Long C.A., Stowers A.W., Zou L., Singh S., Macdonald N.J., et al. Phase 1 study of two merozoite surface protein 1 (MSP1(42)) vaccines for Plasmodium falciparum malaria. PLoS Clin Trials 2 4 (2007) e12